Our patented approach, TLR-AD1, bolsters the body’s own immune system through cellular training; resulting in cancer-fighting cells increasing in number and intelligence.
With TLR-AD1, we will provide Novel Access to the Global market.
Revolutionary advances in the understanding of how our bodies can fight cancer, and how to put that information to use in treating existing tumors. NovAccess Global’s team of experts is working to strengthen the capability of the human body’s defense against cancer.
Stay up-to-date with our journey